三维标测指导下射频导管消融右心耳起源的局灶性房性心动过速

目的 报道应用三维标测指导射频导管消融起源于右心耳的局灶性房性心动过速(房速),并初步探讨其临床及心电学特征.方法 共6例患者(男性4例,女性2例,年龄(43±19)岁]临床诊断为窄QRS心动过速,其中3例曾行常规射频消融失败,4例左心房内径明显扩大.经电生理检查证实为房速.术中行EnSite-NavX激动标测或者Carto电解剖标测以明确局灶性房速并指出最早激动大致范围.在局部做精细标测找到心房最早激动处,于心动过速时应用盐水灌注导管放电消融,能量30～40 W,温度43℃.即刻成功指标为心动过速终止并不再被诱发.结果 6例心动过速平均心动周期为(343±53)ms.三维激动标测结果显示房速呈右心耳部位点状扩布,并且整个右心房激动时间占心动周期的27%±8%.成功消融靶点局部A波较体表心电图P波提前(52±13)ms.消融后行右心房心耳造影确认消融导管位置.6例右心耳房速均成功消融且未有并发症发生.随访3个月其中1例复发心动过速,经再次标测证实为三尖瓣前侧部局灶性房速并且成功消融.左心房扩大者心房内径较术前显著缩小[(41±6)mm对(36±6)mm,P＜0.05].结论 局灶性房速可起源于右心耳并可以成功消融.三维标测有助于靶点定位及消融成功.     

左房房性心动过速三维电磁导管标测系统(Carto)标测与射频消融

目的探讨左房房性心动过速(房速)三维电磁导管标测系统(Carto)系统标测特点及射频消融价值.方法 9例左房房速患者,应用Carto系统标测左心房,实时重建左房三维电解剖图;根据电解剖图,判断房速类型局灶性或大折返性房速;于心房最早激动点处或折返环的关键峡部消融.结果 9例患者中共有10个房速.在冠状静脉窦(CS) 电极中、远端或近端均记录到相对提早A波;9个房速为局灶性房速,激动图显示最早激动点位于肺静脉口部(5个)、左房后壁(2个)、左心耳口部(1个)、左心耳体部(1个);1个为大折返性房速,折返经过右上肺静脉口部与卵圆窝之间关键峡部.8个局灶性房速在上述最早激动点处消融,均成功终止房速,1个左心耳体部房速消融失败;大折返性房速于关键峡部行线性消融,获成功;随访6～30个月,其中1例局灶性房速术后次日复发,再次消融成功;无并发症;成功病例手术时间为90～140 min,X线照射时间为8～16 min.结论本组结果提示,应用Carto系统标测左房房速,判断房速类型准确、快速;指导消融安全、有效,可减少X线照射时间,进一步提高消融成功率,特别是对于常规方法消融失败病例尤有帮助.     

主动脉无冠窦内和二尖瓣环-主动脉连接处射频导管消融局灶性房性心动过速

目的报道13例主动脉无冠窦内和1例二尖瓣环一主动脉连接（MAAJ）处成功消融局灶性房性心动过速（房速）,探讨该类房速的电生理特点及标测和消融方法。方法14例患者,男性3例女性11例,平均年龄（54．4±10．4）岁,均有阵发性房速病史。心房刺激诱发房速后,分析体表心电图P’波特点并于右心房进行激动标测,如果最早心房激动邻近希氏束附近,少数患者在此处消融,其他患者和上述消融不成功患者,经主动脉逆行途径,在无冠窦内标测和消融。如果消融不能成功,则经房间隔穿刺途径至左心房标测最早激动部位处消融。结果房速发作时体表心电图P’波明显变窄（77．8±14．4）ms。右心房激动标测均在希氏束附近标测到相对提前的心房激动,3例于此处消融失败。14例经主动脉逆行途径于无冠窦内标测到最早心房激动提前希氏柬处心房激动0～20．0（10．1±6．3）ms,13例于无冠窦内消融成功,包括1例改用盐水灌注导管后消融成功。1例经无冠窦消融失败后,经穿刺房间隔于MAAJ处标测到最早心房激动处消融成功。随访3～38个月,均无复发。结论对于具有窄P’波及标测右心房最早激动位于希氏束附近的局灶性房速,经主动脉逆行途径在无冠窦内标测和消融具有很高的成功率,经穿刺房间隔在左侧MAAJ处消融或应用盐水灌注导管无冠窦内消融可能进一步提高消融成功率。     

主动脉无冠状窦内射频导管消融前间隔局灶性房性心动过速

目的报告经主动脉无冠状窦内射频消融8例前间隔局灶性房性心动过速(房速)。方法8例患者男性3例,女性5例,平均年龄(50．6±12．3)岁。阵发性房速病史(7．5±5．5)年。术中心房和心室刺激诱发房速,分别在右心房、左心房和主动脉无冠状窦内标测最早心房激动,并进行消融。结果心房刺激能反复诱发和终止8例患者的房速,房速的平均周长(329±66)ms。右心房和左心房的前间隔部位标测相对提前的心房激动,但多次消融未成功。主动脉无冠状窦内的心房激动较希氏束处的心房波提前(11．6±7．2)ms,放电1～2次于8s内终止8例房速。随访(10．2±4．8)个月,无一例房速复发。结论主动脉无冠状窦内可作为消融前间隔局灶性房速的一种新途径,尤其适用于在希氏束部位消融失败的患者。     

主动脉无冠窦内和二尖瓣环-主动脉连接处射频导管消融局灶性房性心动过速

目的报告18例主动脉无冠窦内和1例二尖瓣环-主动脉连接(MAAJ)处成功消融局灶性房性心动过速(房速),探讨该类房速的电生理特点及标测和消融方法。方法 18例患者,女性14例,平均年龄41-71岁,均有阵发性房速病史。心房刺激诱发房速后,分析体表心电图P波特点并于右房进行激动标测,如果最早心房激动邻近希氏束附近,少数患者在此处消融,其他患者和上述消融不成功患者,经主动脉逆行途径,在无冠窦内标测和消融。如果消融不能成功,则经房间隔穿刺途径至左房标测最早激动部位处消融。结果房速发作时体表心电图P波明显变窄(77.8±14.4)ms。右房激动标测均在希氏束附近标测到相对提前的心房激动,3例于此处消融失败。18例经主动脉逆行途径于无冠窦内标测到最早心房激动提前希氏束处心房激动0～20.0(平均10 ms),17例于无冠窦内消融成功,包括1例改用盐水灌注导管后消融成功。1例经无冠窦消融失败后,经穿刺房间隔于MAAJ处标测到最早心房激动处消融成功。随访3～38个月,均无复发。结论对于具有窄P波及标测右房最早激动位于希氏束附近的局灶性房速,经主动脉逆行途径在无冠窦内标测和消融具有很高的成功率,经穿刺房间隔在左侧MAAJ处消融或应用盐水灌注导管无冠窦内消融可能进一步提高消融成功率。     

Carto标测指导下射频导管消融左心耳房性心动过速

目的探讨三维电解剖Carto指导下标测消融源于左心耳部位房性心动过速(房速)的方法和可行性。方法结合电生理和空间信息,首先利用Carto系统建立左心房三维解剖结构。对3例起源于左心耳的房速进行Carto标测,根据Carto标测来确定最早激动点,并以此为靶点进行射频消融。同时分析心动过速时体表心电图的P波特点。结果电解剖标测证实3例房速均为局灶性房速,其最早激动点起源于左心耳,并向左心房前壁、房间隔和后下壁激动。左心耳放电成功消融3例房速。体表心电图分析显示房速时Ⅱ、Ⅲ、aVF和V1导联P波为正向,I、aVL导联为完全负向。结论三维电解剖标测可以清楚显示左心耳解剖结构以及源于其中的房速的激动顺序并有利于经导管进行射频消融。     

经射频导管消融起源于心耳的局灶性房速

目的起源于左、右心耳处的局灶性房性心动过速(房速)比较少见,本研究报告14例起源于左、右心耳的局灶性房速的电生理特性和射频导管消融结果。方法 14例患者年龄为12～55岁,均有反复发作心悸和心动过速的病史,11例心动过速呈无休止发作,抗心律失常药物难以控制,其中3例伴明显左心室增大。电生理检查明确局灶性房速机制,其它机制的室上性心动过速经详细的的电生理检查和心内标测排除。对14例患者均在房速时进行体表心电图分析和激动标测,在心动过速时双极和单极标测所示的最早心房激动部位处行射频导管消融。14例患者中,5例应用CARTO三维标测系统引导标测和消融;除3例患者外,其他11例患者均应用盐水灌注导管消融。结果 10例起源于右心耳的局灶性房速患者,房速时的P’波形态Ⅰ导联和Ⅱ、Ⅲ、aVF导联均为正向波,aVL导联P’波负向、正向、双向者分别是3例、3例和4例;V1导联负向波为主(7/10),V3～V6导联正向波为主(9/10),1例V1～V6导联P波全部为正向波。4例左心耳局灶性房速的P’波形态,Ⅰ和aVL导联均为负向波,Ⅱ、Ⅲ和aVF导联均为正向波,V1～V6导联均为正向波。10例右心耳起源房速均消融成功;4例左心耳起源房速2例消融成功,2例消融失败。14例均无围术期相关并发症发生。在随访期间,右心耳起源房速复发1例,经再次消融成功;其他成功消融患者在未服用抗心律失常药物下无房速复发,3例左心室增大患者随访中左心室基本恢复正常。结论起源于左、右心耳局灶性房速多呈无休止特点,可导致心动过速性心肌病。经射频导管消融心耳部(尤其是右心耳)起源局灶性房速有较高的成功率、较低的复发率和较好的安全性。     

经射频导管消融起源于心耳的局灶性房速

目的起源于左、右心耳处的局灶性房性心动过速(房速)比较少见,本研究报告14例起源于左、右心耳的局灶性房速的电生理特性和射频导管消融结果。方法 14例患者年龄为12～55岁,均有反复发作心悸和心动过速的病史,11例心动过速呈无休止发作,抗心律失常药物难以控制,其中3例伴明显左心室增大。电生理检查明确局灶性房速机制,其它机制的室上性心动过速经详细的的电生理检查和心内标测排除。对14例患者均在房速时进行体表心电图分析和激动标测,在心动过速时双极和单极标测所示的最早心房激动部位处行射频导管消融。14例患者中,5例应用CARTO三维标测系统引导标测和消融;除3例患者外,其他11例患者均应用盐水灌注导管消融。结果 10例起源于右心耳的局灶性房速患者,房速时的P’波形态Ⅰ导联和Ⅱ、Ⅲ、aVF导联均为正向波,aVL导联P’波负向、正向、双向者分别是3例、3例和4例;V1导联负向波为主(7/10),V3～V6导联正向波为主(9/10),1例V1～V6导联P波全部为正向波。4例左心耳局灶性房速的P’波形态,Ⅰ和aVL导联均为负向波,Ⅱ、Ⅲ和aVF导联均为正向波,V1～V6导联均为正向波。10例右心耳起源房速均消融成功;4例左心耳起源房速2例消融成功,2例消融失败。14例均无围术期相关并发症发生。在随访期间,右心耳起源房速复发1例,经再次消融成功;其他成功消融患者在未服用抗心律失常药物下无房速复发,3例左心室增大患者随访中左心室基本恢复正常。结论起源于左、右心耳局灶性房速多呈无休止特点,可导致心动过速性心肌病。经射频导管消融心耳部(尤其是右心耳)起源局灶性房速有较高的成功率、较低的复发率和较好的安全性。     

经主动脉无冠状窦内射频消融治疗房性心动过速

目的:报告经主动脉无冠状窦内射频消融6例局灶性房性心动过速(房速)的消融结果。方法:6例患者中男女各3例。阵发性房速病史(6±3)年。常规心电图、心内电生理,术中心房和心室刺激诱发房速,分别在右心房、左心房和主动脉无冠状窦内标测最早心房激动,并进行射频消融。结果:心房刺激能反复诱发和终止6例患者的房速。心房内的前间隔部位标测相对提前的心房激动,但多次消融未成功。经主动脉无冠状窦内消融成功。平均随访3~17个月,无1例房速复发。结论:经主动脉无冠状窦消融前间隔房速是安全,有效的。     

三维标测下主动脉无冠窦起源局灶性房性心动过速的射频消融效果

目的:分析主动脉无冠窦起源房性心动过速(房速)的心内电生理标测特点及射频消融疗效。方法:对11例主动脉无冠窦起源房速在三维标测系统引导下行心内电生理标测及射频消融治疗。术中构建右心房、希氏束及主动脉根部电解剖模型,测量最早激动点与希氏束的距离,在房速最早激动部位行射频消融治疗。结果:心内电生理检查11例房速皆为局灶起源,右心房激动标测最早激动部位均在希氏束左侧或左后上方,领先冠状窦近端参照A波(21.0±7.9)ms,距希氏束(6.9±3.4)mm。主动脉根部标测房速最早激动部位皆位于无冠窦内,领先冠状窦近端参照A波(35.0±8.6)ms,距希氏束(7.3±4.6)mm;消融终止房速,巩固消融后重复术前诱发条件刺激不能诱发出房速。术中及术后无房室阻滞发生。术后随访6个月,房速无复发。结论:无冠窦起源房速消融安全性和成功率高,标测要点为右心房房速最早激动位于希氏束左侧或左后上方时应常规于主动脉根部标测明确是否无冠窦激动最为领先。     

The immunoneuroendocrine role of melatonin

Abstract: A tight, physiological link between the pineal gland and the immune system is emerging from a series of experimental studies. This link might reflect the evolutionary connection between self-recognition and reproduction. Pinealectomy or other experimental methods which inhibit melatonin synthesis and secretion induce a state of immunodepression which is counteracted by melatonin. In general, melatonin seems to have an immunoenhancing effect that is particularly apparent in immunodepressive states. The negative effect of acute stress or immunosuppressive pharmacological treatments on various immune parameters are counteracted by melatonin. It seems important to note that one of the main targets of melatonin is the thymus, i.e., the central organ of the immune system. The clinical use of melatonin as an immunotherapeutic agent seems promising in primary and secondary immunodeficiencies as well as in cancer immunotherapy. The immunoenhancing action of melatonin seems to be mediated by T-helper cell-derived opioid peptides as well as by lymphokines and, perhaps, by pituitary hormones. Melatonin-induced-immuno-opioids (MHO) and lymphokines imply the presence of specific binding sites or melatonin receptors on cells of the immune system. On the other hand, lymphokines such as -γ-interferon and interleukin-2 as well as thymic hormones can modulate the synthesis of melatonin in the pineal gland. The pineal gland might thus be viewed as the crux of a sophisticated immunoneuroendocrine network which functions as an unconscious, diffuse sensory organ.     

Changes in connexin43, the gap junction protein of astrocytes, during development of the rat pineal gland

Abstract: The abundance of gap junctions between rat pineal astrocytes formed by connexin43 (Cx43) was studied during development. Levels and distribution of Cx43 were measured by immunoblotting and indirect immunofluorescence, respectively. The amount of Cx43 in cells located within the gland was low until about the 7th postnatal day and increased to adult values between the 14th and 21st days postpartum. Although astrocytes, recognized by their vimentin immunoreactivity, were scarce before birth, they were abundant by the 7th postnatal day suggesting that the low levels of Cx43 found at this age corresponded to a low expression of this protein. Localization of the immunoreactivity to Cx43 and vimentin showed a close correlation, indicating that mature or immature pineal astrocytes form gap junctions made of Cx43. Since Cx43 levels attained their adult values at about the time the innervation and the functional state of the gland reached maturity (2–3 weeks after birth), it is proposed that astrocyte gap junctions are involved in the function of the adult rat pineal gland.     

Response of rat pineal melatonin to calcium, magnesium, and lithium is circadian stage dependent

Abstract: Herein we documented the response of pineal melatonin production to electrolytes known to be effective on pineal function in view of a possible circadian stage dependence. We studied the release of melatonin by perifused rat pineal glands at 2 different circadian stages corresponding to the middle of the light and dark periods, i.e., respectively, 7 and 19 HALO (Hours After Light Onset, L:D = 12:12). The initial efflux rates were, as expected, much higher in the perifusates of glands removed from rats sacrificed during the dark phase than of those removed during the light phase. After 3 hr of perifusion, melatonin release reached similar levels which were found constant up to the 8th hr of perifusion, whatever the circadian stage. Perifusion of the glands with physiological concentrations for the rat of calcium (5.2 mmol/1) and magnesium (1.34 mmol/1) resulted in a stimulatory effect on the pineal glands removed from rats sacrificed in the middle of the dark period (19 HALO), whereas no effects were observed on the pineal glands removed from rats sacrificed during the light (7 HALO). Lithium (0.28 and 0.55 mmol/1) was ineffective on melatonin release in pineal glands removed 7 and 19 HALO. Our results show differences in the initial efflux rates of melatonin and in the response of perifused pineal glands to calcium and magnesium according to the circadian stage.     

Conservative management of perforated duodenal diverticulum： A case report and review of the literature

Duodenal diverticula are a relatively common condition. They are asymptomatic, unless they become complicated, with perforation being the rarest but most severe complication. Surgical treatment is the most frequently performed approach. We report the case of a patient with a perforated duodenal diverticulum, which was diagnosed early and treated conservatively with antibiotics and percutaneous drainage of secondary retroperitoneal abscesses. We suggest this method could be an acceptable option for the management of similar cases, provided that the patient is in good general condition and without septic signs.     

Presence of immunoreactive growth hormone and prolactin in the ovine pineal gland

Abstract: The use of antisera raised against bovine growth hormone (GH) and ovine prolactin (PRL) enabled the detection of related immunoreactive (ir) sequences of proteins in ovine pineal tissue. The isolation of PRL-like ir-material was accomplished using a 0.25 M ammonium sulphate (pH 5.5) extraction followed by ethanol precipitation, whereas the resulting 2.0 M ammonium sulphate (pH 7.0) precipitate contained a GH-like immunoreactivity. Gel chromatography of the GH-like immunoreactivity (Sephadex G-100) indicated the presence of several GH-like fragments ranging in the M_r range of 7,000 to 55,000. Analyses of the PRL-like ir-material found in pineal tissue on HPLC using a TSK 545-DEAE column led to the resolution into a single peak of immunoreactivity. A single peak of activity was also observed following chromatofocusing and hydrophobic interaction chromatography of the ir-peak from the TSK 545-DEAE column. The PRL-like ir-material inhibited the binding of [¹²⁵I]ovine PRL-S14 to anti-ovine PRL antibodies without showing an affinity for binding to anti-rat PRL or anti-bovine GH antibodies. Scatchard analysis of the binding of pineal PRL-like ir-material and pituitary ovine PRL-S14 to liver membranes from day-20 pregnant rats revealed similar affinity constants (K_a of 4.7 ± 0.2 × 10⁹ M^-1). In addition, the replication of Nb 2 Node rat lymphoma cells was stimulated by pineal PRL-like ir-material, an effect known to be specific for lactogenic hormones. The pineal PRL-like immunoreactivity appeared on sodium dodecyl sulfate polyacrylamide gels as a single major band of M_r 24,000. The functional status of PRL-and GH-like ir-material in the ovine pineal remains to be determined, but evidence is presented that the overall protein synthesis rate of the rat pineal responded to circulating concentrations of PRL.     

Microbiology of human immunodeficiency virus anorectal disease

PURPOSE: Individuals who are seropositive for the human immunodeficiency virus are at high risk for opportunistic infection and anorectal disorders. Little prospective information is available regarding anorectal pathogens in these patients. METHODS: One hundred sixty-three HIV-seropositive patients presented to the colorectal clinic between 1989 and 1992. Forty-seven (29 percent) patients were thought to have an infectious process and were prospectively studied using a standardized multiculture protocol. RESULTS: Mean age was 33 (range, 19–59) years. All were male; high-risk behavior accounted for 87 percent of HIV transmissions. Presenting complaints included anorectal pain (79 percent), pus per anum (28 percent), and blood per anum (26 percent). Examination revealed perianal tenderness (60 percent), condyloma (38 percent), perianal ulcers (38 percent), and anal fissures (34 percent). Sixty-six sets of cultures were performed; 28 patients had one set, 15 had two sets, and 4 had three sets. Thirty-two of these 47 patients (68 percent) had positive cultures including herpes (50 percent), cytomegalovirus (25 percent),Neisseria gonorrhoeae (16 percent), chlamydia (16 percent), acidfast bacilli (2 percent), and others (9 percent). Six of 32 patients with positive cultures had more than one organism cultured. Sixteen (50 percent) patients with positive cultures were treated medically, 8 (25 percent) were treated surgically and 8 (25 percent) were treated with both modalities. Sixty-one procedures were performed on 17 patients for condylomata. Eighteen patients had 20 procedures for abscesses, 50 percent of whom had positive cultures for other than common bowel flora; all improved. Fourteen patients underwent 33 procedures for perianal fistulas.Mycobacterium fortuitum was cultured from one patient who required 13 procedures for abscesses and fistulas. Forty-five (96 percent) patients were followed for an average of 12.5 months ±2.9 SEM (range, 1–94 months). Symptoms were improved or resolved in 22 of 32 (69 percent) patients with positive cultures and in 11 of 13 (84 percent) with negative cultures. CONCLUSIONS: Specific pathogens may often be identified in human immunodeficiency virus-seropositive patients with anorectal disorders if aggressively sought. Although patients without specific pathogens identified may be expected to improve with planned empiric treatment, positive identification allows more directed therapy.